<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-KSB/A NO. 2
[ ] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 [Fee Required]
For the fiscal year ended _______________
[X] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 [No fee required]
For the transition period from January 1, 1996 to March 31, 1996
Amending Signature Page
Commission file number 0-26202
EASTBROKERS INTERNATIONAL INCORPORATED
(Name of small business issuer in its charter)
Delaware 52-1807562
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
15245 Shady Grove Road, Suite 340, Rockville, Maryland 20850
(Address of principal executive offices) (Zip Code)
(301) 527-1110
(Issuer's telephone number, including area code)
CZECH INDUSTRIES, INC.
(Former name, if changed since last report)
Securities registered under Section 12(b) of the Exchange Act: None.
Securities registered under Section 12(g) of the Exchange Act:
COMMON STOCK
CLASS A WARRANTS
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Check if there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-B contained in this form, and no disclosure will be contained, to
the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-KSB or any
amendment to this Form 10-KSB. [X ]
The issuer's revenue for the most recent fiscal year is $399,218.
The aggregate market value of the Common stock held by non-affiliates computed
by reference to the average bid and asked prices of such stock on May 31, 1996
was approximately $16,444,818.
As of June 1, 1996, the Registrant had 8,905,000 shares of Common Stock, par
value $0.01, issued and outstanding.
Transitional Small Business Disclosure Format (Check One): Yes No X
--- ---
<PAGE>
The 10-KSB for the transition period from January 1, 1996 to March 31, 1996 is
being amended to include Dr. Michael Sumichrast's signature in his capacity as a
director of the Company at the time of the original filing.
- 2 -
<PAGE>
SIGNATURES
In accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
(Registrant) CZECH INDUSTRIES, INC.
------------------------------------------
By (Signature and Title) /s/ Dr. Michael Sumichrast Date 6/28/96
---------------------------------- ----------
Dr. Michael Sumichrast,
Chairman of the Board
In accordance with the Exchange Act, this report has been signed below by
the following persons on behalf of the registrant and in the capacities and on
the dates indicated.
By (Signature and Title) /s/ Ing. Petr Bednarik Date 6/28/96
---------------------------------- ----------
Ing. Petr Bednarik,
Chief Executive Officer,
President, Director
By (Signature and Title) /s/ Randall Greene Date 6/28/96
---------------------------------- ----------
Randall Greene, Director
By (Signature and Title) Date
---------------------------------- ----------
Ing. Petr Holub, Director
By (Signature and Title) Date
---------------------------------- ----------
Ing. Miroslav Kerous, Director
By (Signature and Title) Date
---------------------------------- ----------
Robert C, McFarlane, Director
By (Signature and Title) /s/ Peter Schmid Date 6/28/96
--------------------------------- ----------
Peter Schmid, Director
By (Signature and Title) /s/ Martin A. Sumichrast Date 6/28/96
--------------------------------- ----------
Martin A. Sumichrast,
Chief Financial Officer,
Director
By (Signature and Title) Date
--------------------------------- ----------
JUDr. Dalibor Vitek, Director
- 3 -
<PAGE>
SIGNATURES (Continued)
In accordance with the Exchange Act, this report has been signed below by
the following persons on behalf of the registrant and in the capacities and on
the dates indicated.
By (Signature and Title) /s/ Dr. Michael Sumichrast Date 7/22/97
---------------------------------- ----------
Dr. Michael Sumichrast,
Director
- 4 -
